Johnson Controls, GlaxoSmithKline Agreement Brings Engineering Best Practices To R&D Facilities

    MILWAUKEE, Jan. 31 A new five-year contract between
GlaxoSmithKline (GSK) and Johnson Controls strengthens the
relationship between the companies by bringing a designated engineering team's
expertise to three former SmithKline Beecham pharmaceutical research and
development centers in England.
    The team of more than 120 Johnson Controls engineers provides
round-the-clock service to the R&D facilities at Harlow, Welwyn and Tonbridge,
England, under the agreement.  The working relationship between the two
companies began with a 1995 engineering service contract covering the
Tonbridge site.
    Under the agreement, Johnson Controls is responsible for heating,
ventilation and air conditioning (HVAC) systems; instrumentation and controls
calibration; specialist laboratory equipment installation; programming all
programmable logic controllers; collecting data on equipment; and operating
and maintenance of steam plants.  Johnson Controls also operates a dispatch
center to handle scientific engineering requests and adjustments to
temperature and humidity.  All data is placed on GSK's computerized
maintenance management system.  The processes fully support the demands of
Good Manufacturing Practice and Good Laboratory Practice standards.
    The on-site personnel are assigned by function to best meet GSK's business
processes, respond to needs and make the most efficient use of resources.
    Johnson Controls has also created a technical support team to develop
innovative and specialty technical building control solutions to meet the
overall future needs and objectives for the GSK research and development
business.
    The agreement introduces a much greater level of measurement and feedback
that sets financial performance and site quality benchmarks that are used to
evaluate Johnson Controls.  Business objectives are reviewed on a quarterly
basis and the GSK staff will provide feedback through regular surveys.
    "This relationship we have with GlaxoSmithKline has moved far beyond the
conventional client contractor relationship to a partnership that's based on
trust and the ability to deliver," said Brian Stark, president of the Controls
business at Johnson Controls. "We value the trust that GlaxoSmithKline has
placed in us and will work hard to deliver the best in efficiency and
service."
    "Johnson Controls has demonstrated that they could bring to the table the
type of service that R&D demanded for the future -- a new and innovative
contract organization and methods that would support the ever-changing face of
GSK's pharmaceutical research," said Steve Hartles, GSK Engineering Director
for the three sites.
    The partnership is already paying off for GSK.  A special energy forum
team, that includes a Johnson Controls energy expert, has identified $363,000
in potential energy savings at the R&D facilities.
    GlaxoSmithKline (GSK), one of the world's leading research-based
pharmaceutical and health care companies, is committed to improving the
quality of human life by enabling people to do more, feel better and live
longer.
    Johnson Controls, Inc., is a global market leader in automotive systems
and facility management and control.  In the automotive market, it is a major
supplier of seating and interior systems and batteries.  For nonresidential
facilities, Johnson Controls provides building control systems and services,
energy management and integrated facility management.  Johnson Controls,
founded in 1885, has headquarters in Milwaukee, Wis.  Its sales for 2000
totaled $17.2 billion.  Visit http://www.johnsoncontrols.com